PARP1 and lip and oral cavity carcinoma: Upon treatment with cisplatin and 5-FU, two chemotherapeutic drugs used for oral cancer, PARP1 expression was further increased in SCC11B, by approximately 50 and 100%, respectively (Figure 1C).